265 related articles for article (PubMed ID: 30659922)
21. Tailoring drug release in bilayer tablets through droplet deposition modeling and injection molding.
Ebrahimi F; Xu H; Fuenmayor E; Major I
Int J Pharm; 2024 Mar; 653():123859. PubMed ID: 38307401
[TBL] [Abstract][Full Text] [Related]
22. Fabrication of Taste-Masked Donut-Shaped Tablets Via Fused Filament Fabrication 3D Printing Paired with Hot-Melt Extrusion Techniques.
Wang H; Dumpa N; Bandari S; Durig T; Repka MA
AAPS PharmSciTech; 2020 Aug; 21(7):243. PubMed ID: 32856144
[TBL] [Abstract][Full Text] [Related]
23. 3D-Printed Network Structures as Controlled-Release Drug Delivery Systems: Dose Adjustment, API Release Analysis and Prediction.
Korte C; Quodbach J
AAPS PharmSciTech; 2018 Nov; 19(8):3333-3342. PubMed ID: 29855799
[TBL] [Abstract][Full Text] [Related]
24. Evaluation of hot-melt extrusion and injection molding for continuous manufacturing of immediate-release tablets.
Melocchi A; Loreti G; Del Curto MD; Maroni A; Gazzaniga A; Zema L
J Pharm Sci; 2015 Jun; 104(6):1971-1980. PubMed ID: 25761921
[TBL] [Abstract][Full Text] [Related]
25. Integrated hot-melt extrusion - injection molding continuous tablet manufacturing platform: Effects of critical process parameters and formulation attributes on product robustness and dimensional stability.
Desai PM; Hogan RC; Brancazio D; Puri V; Jensen KD; Chun JH; Myerson AS; Trout BL
Int J Pharm; 2017 Oct; 531(1):332-342. PubMed ID: 28844899
[TBL] [Abstract][Full Text] [Related]
26. 3D extrusion printing of high drug loading immediate release paracetamol tablets.
Khaled SA; Alexander MR; Wildman RD; Wallace MJ; Sharpe S; Yoo J; Roberts CJ
Int J Pharm; 2018 Mar; 538(1-2):223-230. PubMed ID: 29353082
[TBL] [Abstract][Full Text] [Related]
27. Manufacturing of hybrid drug delivery systems by utilizing the fused filament fabrication (FFF) technology.
Eleftheriadis GK; Katsiotis CS; Genina N; Boetker J; Rantanen J; Fatouros DG
Expert Opin Drug Deliv; 2020 Aug; 17(8):1063-1068. PubMed ID: 32511025
[TBL] [Abstract][Full Text] [Related]
28. Preparation and investigation of novel gastro-floating tablets with 3D extrusion-based printing.
Li Q; Guan X; Cui M; Zhu Z; Chen K; Wen H; Jia D; Hou J; Xu W; Yang X; Pan W
Int J Pharm; 2018 Jan; 535(1-2):325-332. PubMed ID: 29051121
[TBL] [Abstract][Full Text] [Related]
29. Low temperature fused deposition modeling (FDM) 3D printing of thermolabile drugs.
Kollamaram G; Croker DM; Walker GM; Goyanes A; Basit AW; Gaisford S
Int J Pharm; 2018 Jul; 545(1-2):144-152. PubMed ID: 29705104
[TBL] [Abstract][Full Text] [Related]
30. A flexible-dose dispenser for immediate and extended release 3D printed tablets.
Pietrzak K; Isreb A; Alhnan MA
Eur J Pharm Biopharm; 2015 Oct; 96():380-7. PubMed ID: 26277660
[TBL] [Abstract][Full Text] [Related]
31. How to Obtain the Maximum Properties Flexibility of 3D Printed Ketoprofen Tablets Using Only One Drug-Loaded Filament?
Pyteraf J; Jamróz W; Kurek M; Szafraniec-Szczęsny J; Kramarczyk D; Jurkiewicz K; Knapik-Kowalczuk J; Tarasiuk J; Wroński S; Paluch M; Jachowicz R
Molecules; 2021 May; 26(11):. PubMed ID: 34067434
[TBL] [Abstract][Full Text] [Related]
32. The applicability of pharmaceutical polymeric blends for the fused deposition modelling (FDM) 3D technique: Material considerations-printability-process modulation, with consecutive effects on in vitro release, stability and degradation.
Ilyés K; Kovács NK; Balogh A; Borbás E; Farkas B; Casian T; Marosi G; Tomuță I; Nagy ZK
Eur J Pharm Sci; 2019 Mar; 129():110-123. PubMed ID: 30610954
[TBL] [Abstract][Full Text] [Related]
33. 3D printing tablets for high-precision dose titration of caffeine.
Krueger L; Cao Y; Zheng Z; Ward J; Miles JA; Popat A
Int J Pharm; 2023 Jul; 642():123132. PubMed ID: 37315638
[TBL] [Abstract][Full Text] [Related]
34. Fabrication of an osmotic 3D printed solid dosage form for controlled release of active pharmaceutical ingredients.
Gioumouxouzis CI; Tzimtzimis E; Katsamenis OL; Dourou A; Markopoulou C; Bouropoulos N; Tzetzis D; Fatouros DG
Eur J Pharm Sci; 2020 Feb; 143():105176. PubMed ID: 31809907
[TBL] [Abstract][Full Text] [Related]
35. An Effective Technology for the Development of Immediate Release Solid Dosage Forms Containing Low-Dose Drug: Fused Deposition Modeling 3D Printing.
Gültekin HE; Tort S; Acartürk F
Pharm Res; 2019 Jun; 36(9):128. PubMed ID: 31250313
[TBL] [Abstract][Full Text] [Related]
36. Development of mechanistic models to identify critical formulation and process variables of pastes for 3D printing of modified release tablets.
Zidan A; Alayoubi A; Asfari S; Coburn J; Ghammraoui B; Aqueel S; Cruz CN; Ashraf M
Int J Pharm; 2019 Jan; 555():109-123. PubMed ID: 30453019
[TBL] [Abstract][Full Text] [Related]
37. The impact of the injection mold temperature upon polymer crystallization and resulting drug release from immediate and sustained release tablets.
Van Renterghem J; Dhondt H; Verstraete G; De Bruyne M; Vervaet C; De Beer T
Int J Pharm; 2018 Apr; 541(1-2):108-116. PubMed ID: 29409747
[TBL] [Abstract][Full Text] [Related]
38. Design and characterization of a novel 3D printed pressure-controlled drug delivery system.
Krause J; Bogdahn M; Schneider F; Koziolek M; Weitschies W
Eur J Pharm Sci; 2019 Dec; 140():105060. PubMed ID: 31499171
[TBL] [Abstract][Full Text] [Related]
39. A comparison of droplet deposition modelling, fused filament fabrication, and injection moulding for the production of oral dosage forms containing hydrochlorothiazide.
Ebrahimi F; Xu H; Fuenmayor E; Major I
Int J Pharm; 2023 Oct; 645():123400. PubMed ID: 37696342
[TBL] [Abstract][Full Text] [Related]
40. Fabricating a Shell-Core Delayed Release Tablet Using Dual FDM 3D Printing for Patient-Centred Therapy.
Okwuosa TC; Pereira BC; Arafat B; Cieszynska M; Isreb A; Alhnan MA
Pharm Res; 2017 Feb; 34(2):427-437. PubMed ID: 27943014
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
